Raimar Löbenberg
Chairman presso DEFENCE THERAPEUTICS INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Raimar Löbenberg is the founder of RS Therapeutics, Inc. He currently holds the position of Chairman at Defence Therapeutics Inc and Independent Director at BioNxt Solutions, Inc. He is also the Co-Managing Director at Vektor Pharma TF GmbH.
In addition, he has been a Professor of Pharmacy & Pharmaceutical at the University of Alberta since 2000.
Previously, he served as the President of the Canadian Society for Pharmaceutical Sciences from 2014 to 2015.
Dr. Löbenberg obtained his doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main and his undergraduate degree from The Johannes Gutenberg University of Mainz.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIONXT SOLUTIONS INC
4.72% | 03/04/2023 | 5 000 000 ( 4.72% ) | 2 M $ | 31/03/2024 |
| 02/11/2023 | 100 000 ( 0.22% ) | 125 000 $ | 31/03/2024 |
Posizioni attive di Raimar Löbenberg
| Società | Posizione | Inizio |
|---|---|---|
| BIONXT SOLUTIONS INC. | Director/Board Member | 10/12/2018 |
| DEFENCE THERAPEUTICS INC. | Chairman | 05/01/2021 |
| University of Alberta | Corporate Officer/Principal | 01/01/2000 |
| RS Therapeutics, Inc. | Founder | - |
Vektor Pharma TF GmbH
 Vektor Pharma TF GmbH Pharmaceuticals: MajorHealth Technology Vektor Pharma TF GmbH engages in the development and production of transdermal systems. It is a narcotics company that focuses on the research, development and production of therapeutic films for pharmaceuticals, cosmetics and food. The firm offers formulation development, pharmaceutical analysis, machinery for development and production, and consultation products. The company was founded in 2009 and is headquartered in Uttenweiler, Germany. | Chief Executive Officer | - |
Precedenti posizioni note di Raimar Löbenberg
| Società | Posizione | Fine |
|---|---|---|
| Canadian Society for Pharmaceutical Sciences | President | 01/01/2015 |
Formazione di Raimar Löbenberg
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
| The Johannes Gutenberg University of Mainz | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BIONXT SOLUTIONS INC. | Health Technology |
| DEFENCE THERAPEUTICS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
| Canadian Society for Pharmaceutical Sciences | |
| RS Therapeutics, Inc. | |
Vektor Pharma TF GmbH
Vektor Pharma TF GmbH Pharmaceuticals: MajorHealth Technology Vektor Pharma TF GmbH engages in the development and production of transdermal systems. It is a narcotics company that focuses on the research, development and production of therapeutic films for pharmaceuticals, cosmetics and food. The firm offers formulation development, pharmaceutical analysis, machinery for development and production, and consultation products. The company was founded in 2009 and is headquartered in Uttenweiler, Germany. | Health Technology |
- Borsa valori
- Insiders
- Raimar Löbenberg
